Derm Pharm Flashcards
Absorption is enhanced when
Stratum corners is thinner (scrotum, face, axilla)
Skin integrity is compromised
Temperature increased
Increased hydration
Increased concentration
The more ____ the vehicle, the more hydrated the skin is
Occlusive
More hydrated skin = more absorption of drug
Rank the vehicles from best absorption to worst
Ointment –> cream —> lotion –> gels (worst)
Creams
Semisolid emulsions of oil
Easily washed off with water
Middle ground potentcy
Ointments
Water suspended in oil, excellent lubricant
Decreases water loss, enhances absorption
MOST potent due to occlusive effect
Patient acceptance is low (greasy) and not good in hair areas
Lotions
Powder in water so you must shake before use
Cooling and drying but least potent
Useful in large hair areas
MOA of topical corticosteroids
Act against inflammation at cellular level
Inhibition of formation, release, and activity of mediators of inflammation –> decreases inflammation
Inhibits the migration of macrophages and leukocytes (reverses vascular dilation and permability)
Antimitotic effect on epidermal cells
When topical agents are applied to skin (Big Macs)
Inhibit migration of macrophages and leukocytes to reverse vascular dilation and permeability
Decreases edema, pruritis, edema
Absorption of topical corticosteroids increases with:
Increased hydration
Breaks in skin
Metabolism of topical corticosteroids
Primarily in the liver
Some in the skin
Elimination is primarily in the kidney
Potency of topical corticosteroids is dependent upon
- Characteristics of the drug (fluorinated to make more potent)
- Concentration of the drug
- Vehicle for delivery
General approach to topical corticosteroids
Start with lower potency, less occlusive vehicles (creams) then titrate up
Thin film of preparation
Only low-mid potency for children and short duration
What corticosteroids should be used on the face?
Non fluorinated/low potency areas
Used in all areas with thin stratum corneum
High potency can be used for BREIF periods
Lowest efficacy corticosteroid (concentration)
Hydrocortisone (0.25-2.5%)
Low efficacy corticosteroid (concentration)
Triamcinolone actinide/Aristocort Kenalog (0.025%)
Intermediate efficacy corticosteroid (concentration)
4
Hydrocortisone valerate/Westcort (0.1%)
Flurandrenolide/Cordran (0.025%)
Desonide/Desowen (0.05%)
Triamcinolone acetonide/kenalog (0.1%)
High efficacy corticosteroid (concentration)
3
Fluocinonide/Lidex (0.05%)
Triamcinolone acetonide/Kenalog (0.5)
Desoximetasone/Topicort (0.25%)
Highest efficacy corticosteroid (concentration)
Clobetasole propionate/Temovate (0.05%)
Intralesional corticosteroids
Preparations that are insoluble upon injection and solubility gradually
Ex. Triamcinolone acetonide/Kenalog-10
Triamcinolone acetonide
Intradermal
Limited to 1.0mg per injection site
Multiple sites can be injected
Greater volume of corticosteroid injected results in greater likelihood of systemic absorption/effects
Adverse reactions to topical corticosteroids
- HPA suppression
- Excessive absorption = Cushing’s disease, hyperglycemia, and hypokalemia
Under most conditions systemic absorption is very minimal and therefore these ADRs are minimal
When do we worry about systemic involvement of topical corticosteroids
- High potency agents in occlusive preparations
- Large amounts of topical over large area of the body
- Topical corticosteroids over breaks in the skin
- Topical corticosteroids in pediatric patients
Most significant ADR Topical corticosteroids
Skin thinning/atrophy
Secondary infection due to immunosuppression
Tolerance (reversible if used cyclically)
Pathogens from most dermatological concerts are
Group A b-hemolytic streptococcus
Staphylococcus aureus
We try to cover these but also take into account regional patterns of resistance (Antibiogram)